• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Hero Background
    English
    Chinese
    French
    Japanese
    Korean
    German
    Spanish

    Beta Glucan Market Size

    ID: MRFR/F-B & N/0218-HCR
    128 Pages
    Snehal Singh
    October 2025

    Beta-Glucan Market Research Report Information By Source (Yeast, Mushroom, Cereals, and Microalgae), By Application (Food & Beverages, Animal Feed, Personal Care, Pharmaceuticals, and Others), By Type ((1,3) Beta Glucan, (1,4) Beta Glucan, and (1,6) Beta Glucan), and By Region (North America, Europe, Asia-Pacific, and Rest Of The World) – Market Forecast Till 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Beta Glucan Market Infographic
    Purchase Options

    Beta Glucan Size

    Beta Glucan Market Growth Projections and Opportunities

    The Beta Glucan market has witnessed significant growth in recent years, driven by increasing consumer awareness of its health benefits and rising demand for functional food and dietary supplements. Beta glucan, a type of soluble fiber found in oats, barley, mushrooms, and yeast, has gained popularity for its immune-boosting properties and potential to lower cholesterol levels. In response to growing health concerns and a shift towards preventive healthcare, consumers are seeking products enriched with beta glucan, contributing to the expansion of the market.

    One notable trend in the beta glucan market is the rising demand for natural and organic products. With an increasing emphasis on clean label and transparent sourcing, consumers are gravitating towards natural sources of beta glucan, such as oats and mushrooms, over synthetic alternatives. This trend aligns with broader consumer preferences for wholesome, minimally processed ingredients, driving manufacturers to incorporate beta glucan into a wide range of natural and organic products, including beverages, snacks, and supplements.

    Another key trend shaping the beta glucan market is the growing interest in immune health. In light of recent global health crises and heightened awareness of the importance of immunity, consumers are actively seeking out products that support immune function. Beta glucan's ability to enhance immune response by activating white blood cells known as macrophages has positioned it as a valuable ingredient in immune-supporting supplements and functional foods. As a result, manufacturers are increasingly incorporating beta glucan into formulations targeting immune health, driving market growth.

    Furthermore, the beta glucan market is experiencing expansion driven by the rising prevalence of lifestyle-related diseases such as obesity, diabetes, and cardiovascular disorders. Clinical studies have demonstrated beta glucan's potential to regulate blood sugar levels, improve insulin sensitivity, and reduce LDL cholesterol, making it a sought-after ingredient in products targeting metabolic health. With the global burden of chronic diseases on the rise, consumers are turning to dietary interventions like beta glucan to manage their health, fueling market growth in this segment.

    Moreover, advancements in food processing technologies are opening up new opportunities for beta glucan incorporation into a variety of food and beverage applications. Innovations such as microencapsulation and nanoemulsification allow for the efficient delivery of beta glucan without compromising product quality or sensory attributes. This has led to the development of beta glucan-fortified products that offer enhanced functionality without sacrificing taste or texture, driving consumer acceptance and market expansion.

    Additionally, the beta glucan market is witnessing increased penetration across diverse end-use industries, including pharmaceuticals, cosmetics, and animal nutrition. In pharmaceuticals, beta glucan's immunomodulatory properties are being explored for the development of novel therapies for conditions such as cancer and inflammatory diseases. In cosmetics, beta glucan is valued for its moisturizing and anti-aging effects, driving its incorporation into skincare formulations. In animal nutrition, beta glucan is utilized to enhance immune function and promote gut health in livestock and companion animals, reflecting its broad applicability across sectors.

    Beta Glucan Market Size Graph
    Author
    Snehal Singh
    Assistant Manager - Research

    High acumen in analyzing complex macro & micro markets with more than 6 years of work experience in the field of market research. By implementing her analytical skills in forecasting and estimation into market research reports, she has expertise in Packaging, Construction, and Equipment domains. She handles a team size of 20-25 resources and ensures smooth running of the projects, associated marketing activities, and client servicing.

    Leave a Comment

    FAQs

    How much is the Beta-Glucan market?

    The Beta-Glucan Market size was valued at USD 1.4 Billion in 2023.

    What is the growth rate of the Beta-Glucan market?

    The global market is projected to grow at a CAGR of 5.03% during the forecast period, 2024-2032.

    Which region held the largest market share in the Beta-Glucan market?

    North America had the largest share in the global market

    Who are the key players in the Beta-Glucan market?

    The key players in the market are Kerry Group plc., Givaudan SA, Koninklijke DSM N.V., Euglena Co. Ltd, Biotec Pharmacon ASA, Tate & Lyle plc., Lesaffre Group, Kemin Industries, Inc., ABF Ingredients, Super Beta Glucan, and Garuda International, Inc.

    Which Source led the Beta-Glucan market?

    The Yeast Source dominated the market in 2023.

    Which Application had the largest market share in the Beta-Glucan market?

    The Food & Beverages Application had the largest share in the global market.

    Market Summary

    As per MRFR analysis, the Beta-Glucan Market Size was estimated at 1.485 USD Billion in 2024. The Beta-Glucan industry is projected to grow from 1.56 in 2025 to 2.548 by 2035, exhibiting a compound annual growth rate (CAGR) of 5.03 during the forecast period 2025 - 2035.

    Key Market Trends & Highlights

    The Beta-Glucan Market is experiencing robust growth driven by health trends and technological advancements.

    • North America remains the largest market for beta-glucan, driven by increasing health consciousness among consumers.
    • The Asia-Pacific region is emerging as the fastest-growing market, fueled by rising demand for natural ingredients in various applications.
    • Yeast-derived beta-glucan continues to dominate the market, while microalgae-based products are gaining traction due to their health benefits.
    • Key market drivers include the increasing demand for functional foods and the rising incidence of chronic diseases, which are shaping consumer preferences.

    Market Size & Forecast

    2024 Market Size 1.485 (USD Billion)
    2035 Market Size 2.548 (USD Billion)
    CAGR (2025 - 2035) 5.03%
    Largest Regional Market Share in 2024 North America

    Major Players

    <p>Kerry Group (IE), DSM Nutritional Products (CH), Cargill, Incorporated (US), Nutraceutical Corporation (US), FMC Corporation (US), BASF SE (DE), Kemin Industries, Inc. (US), OatWell (SE), MGP Ingredients, Inc. (US)</p>

    Market Trends

    The Beta-Glucan Market is currently experiencing a notable transformation, driven by increasing consumer awareness regarding health and wellness. This shift appears to be influencing demand for natural ingredients, particularly those associated with immune support and cardiovascular health. As a result, various industries, including food and beverages, pharmaceuticals, and cosmetics, are integrating beta-glucan into their products. This trend suggests a growing recognition of the potential health benefits associated with beta-glucan, which may lead to broader applications across diverse sectors. Moreover, the Beta-Glucan Market seems to be benefiting from advancements in extraction and processing technologies. These innovations could enhance the quality and bioavailability of beta-glucan, making it more appealing to manufacturers and consumers alike. Additionally, the rise of e-commerce platforms is likely facilitating greater accessibility to beta-glucan products, thereby expanding market reach. As the landscape evolves, stakeholders may need to adapt to changing consumer preferences and regulatory frameworks to capitalize on emerging opportunities.

    Rising Health Consciousness

    There is a growing trend of health awareness among consumers, leading to increased interest in natural ingredients like beta-glucan. This shift is prompting various sectors to incorporate beta-glucan into their offerings, particularly in health supplements and functional foods.

    Technological Advancements in Extraction

    Innovations in extraction and processing methods are enhancing the quality and efficacy of beta-glucan. These advancements may improve the ingredient's bioavailability, making it more attractive for manufacturers aiming to meet consumer demands.

    Expansion of E-commerce Channels

    The proliferation of e-commerce platforms is likely increasing the accessibility of beta-glucan products. This trend may facilitate broader market penetration, allowing consumers to easily find and purchase products containing this beneficial ingredient.

    The increasing recognition of beta-glucan's health benefits, particularly in immune support and cholesterol management, appears to drive its demand across various sectors, including food, pharmaceuticals, and cosmetics.

    U.S. Department of Agriculture

    Beta Glucan Market Market Drivers

    Regulatory Support for Health Claims

    The Beta-Glucan Market benefits from increasing regulatory support for health claims associated with beta-glucan consumption. Regulatory bodies in various regions are recognizing the health benefits of beta-glucan, particularly its role in cholesterol management and heart health. This endorsement is likely to encourage food manufacturers to incorporate beta-glucan into their products, as it allows them to market these items with credible health claims. The potential for beta-glucan to be included in dietary guidelines further enhances its marketability. As consumers become more informed about health benefits, the regulatory backing could lead to a broader acceptance and utilization of beta-glucan in various food applications.

    Rising Incidence of Chronic Diseases

    The prevalence of chronic diseases such as diabetes, obesity, and cardiovascular conditions is escalating, which appears to be a significant driver for the Beta-Glucan Market. Research indicates that beta-glucan may play a role in managing blood sugar levels and reducing cholesterol, making it an appealing ingredient for health-conscious consumers. As healthcare systems worldwide grapple with the burden of chronic illnesses, there is a growing emphasis on dietary interventions. The market for beta-glucan is projected to expand as food manufacturers incorporate this ingredient into products aimed at disease prevention and management. This trend suggests a potential increase in product innovation and diversification within the beta-glucan sector.

    Increasing Demand for Functional Foods

    The Beta-Glucan Market is experiencing a notable surge in demand for functional foods, driven by a growing consumer awareness regarding health and wellness. As individuals increasingly seek dietary supplements that offer health benefits, products containing beta-glucan are gaining traction. This polysaccharide, primarily derived from oats and barley, is recognized for its potential to enhance immune function and lower cholesterol levels. Market data indicates that the functional food sector is projected to grow at a compound annual growth rate (CAGR) of approximately 8% over the next five years, suggesting a robust opportunity for beta-glucan products. The rising inclination towards preventive healthcare is likely to further bolster the market, as consumers prioritize nutrition that supports overall well-being.

    Growing Interest in Natural Ingredients

    The Beta-Glucan Market is witnessing a shift towards natural and organic ingredients, as consumers become more discerning about the products they consume. This trend is particularly evident in the food and beverage sector, where there is a marked preference for clean-label products. Beta-glucan, being a naturally occurring polysaccharide, aligns well with this consumer demand for transparency and healthfulness. Market analysis reveals that the clean-label food market is expected to grow significantly, with a projected CAGR of around 7% in the coming years. This inclination towards natural ingredients is likely to enhance the appeal of beta-glucan, as manufacturers seek to meet consumer expectations for wholesome and minimally processed foods.

    Technological Innovations in Production

    The Beta-Glucan Market is poised for growth due to technological advancements in the extraction and production processes of beta-glucan. Innovations in biotechnology and extraction methods are enhancing the efficiency and yield of beta-glucan, making it more accessible for manufacturers. These advancements not only improve the cost-effectiveness of production but also ensure higher purity and quality of the final product. Market data suggests that the introduction of novel extraction techniques could potentially reduce production costs by up to 20%, thereby encouraging more companies to enter the beta-glucan market. As production becomes more streamlined, the availability of beta-glucan in various forms is likely to increase, catering to diverse consumer preferences.

    Market Segment Insights

    By Source: Yeast (Largest) vs. Microalgae (Fastest-Growing)

    <p>In the Beta-Glucan Market, the source segment is predominantly represented by yeast, which captures the largest share due to its established applications in health supplements and pharmaceuticals. Following yeast, cereals and mushrooms contribute significant values, but lag behind yeast in overall market presence. Microalgae, while currently smaller in share, is emerging rapidly as a viable and sustainable source for beta-glucans, appealing to the increasing demand for natural and plant-based ingredients.</p>

    <p>Yeast (Dominant) vs. Microalgae (Emerging)</p>

    <p>Yeast is recognized as the dominant source of beta-glucans, favored for its high yield and efficacy in various applications such as dietary supplements and functional foods. Its longstanding presence in the market has made it a trusted choice for consumers and manufacturers alike. On the other hand, microalgae stands out as the emerging source, driven by innovations in cultivation techniques and a growing trend towards sustainability. The unique bioactive properties of microalgae are garnering interest from health-conscious consumers, positioning it as a promising alternative that could reshape the market dynamics in the coming years.</p>

    By Application: Food & Beverages (Largest) vs. Pharmaceuticals (Fastest-Growing)

    <p>The Beta-Glucan Market showcases a diverse range of applications, with Food & Beverages holding the largest share due to the growing consumer demand for health-beneficial ingredients. Products containing beta-glucans in this segment often emphasize immune support and heart health, which resonate well with today's health-conscious consumers. In contrast, Pharmaceuticals represents the fastest-growing segment, propelled by the increasing focus on curative health solutions harnessing the potential of beta-glucans for chronic disease management and therapeutic applications.</p>

    <p>Food & Beverages: Dominant vs. Pharmaceuticals: Emerging</p>

    <p>Food & Beverages is the dominant segment within the Beta-Glucan Market, as its applications in health foods, dietary supplements, and functional beverages continue to expand. The segment thrives on the rising trend of healthy eating and a preference for natural ingredients, positioning beta-glucans as key components for enhancing nutritional value. On the other hand, Pharmaceuticals is emerging rapidly, driven by healthcare advancements and the increasing recognition of beta-glucans as immunomodulators. This segment is attracting significant attention from researchers and developers hoping to capitalize on beta-glucans' potential to improve patient outcomes, therefore signaling an important shift in the market dynamics.</p>

    By Type: (1,3) Beta Glucan (Largest) vs. (1,6) Beta Glucan (Fastest-Growing)

    <p>In the Beta-Glucan Market, the distribution of market share among various types reveals a clear dominance of (1,3) Beta Glucan. This segment captures a significant portion of the market, primarily due to its extensive application in dietary supplements and functional foods. Its established presence is crucial as it serves as a key ingredient recognized for its immune-boosting and cholesterol-lowering properties, resulting in a robust consumer base. In contrast, (1,6) Beta Glucan is emerging as a fast-growing segment, appealing to segments looking for innovative health solutions. As research continues to unveil the unique benefits associated with (1,6) Beta Glucan, it is gaining traction among manufacturers aiming to develop specialized health products.</p>

    <p>(1,4) Beta Glucan (Dominant) vs. (1,6) Beta Glucan (Emerging)</p>

    <p>(1,4) Beta Glucan plays a dominant role in the Beta-Glucan Market, primarily because of its critical applications in food products, such as bakery and dairy items, which are gaining popularity for their health benefits. This segment is characterized by its functionality as a soluble fiber, which supports digestive health and acts as a prebiotic. Meanwhile, the (1,6) Beta Glucan segment is recognized as emerging, marked by increasing research interest and potential applications in clinical settings. The distinct ways both types interact with the human body also position them uniquely in the market. (1,6) Beta Glucan's properties are being explored for immunomodulatory effects, appealing to health-conscious consumers and driving innovation in product formulations.</p>

    Get more detailed insights about Beta-Glucan Market Research Report—Global Forecast till 2032

    Regional Insights

    By region, the study provides the market insights into North America, Europe, Asia-Pacific and Rest of the World. The North America Beta-Glucan Market dominated this market in 2022 (45.80%). American companies Merck and Lesaffre are among the major market participants in the North American beta-glucan industry. Beta-glucan is now widely used in the food and beverage industry as thickening agents, fat substitutes, dietary fiber, and hypocholesterolemic agents; these are believed to be the factors driving the rise in the area. Further, the U.S.

    Beta-Glucan held the largest market share, and the Canada market of beta-glucan was the fastest growing market in the North America region.

    Further, the major countries studied in the market report are The US, Canada, German, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.

    Figure 2: BETA-GLUCAN MARKET SHARE BY REGION 2022 (USD Billion)

    BETA-GLUCAN MARKET SHARE BY REGION 2022

    Source: Secondary Research, Primary Research, Market Research Future Database and Analyst Review

    Europe Beta-Glucan market accounted for the healthy market share in 2022. Because European consumers are calorie cautious, low-calorie and low-fat food products are well-liked in the continent. The frequency of obesity and cardiovascular disorders is rising, which has increased consumer demand for food products made from natural, low-calorie ingredients. Further, the German Beta-Glucan held the largest market share, and the U.K market of beta-glucan was the fastest growing market in the European region

    The Asia Pacific Beta-Glucan market is expected to register significant growth from 2023 to 2032. The demand for products in this region is being supported by a large number of food processing, cosmetics, and personal care product manufacturing businesses in Asian nations like India, China, South Korea, and Japan. In terms of income, demography, and dietary needs, the area is very diverse. Consumers' increased purchasing power and the rising demand for food products with improved nutritional values are anticipated to have a favourable effect on industry growth.

    Moreover, China’s Beta-Glucan held the largest market share, and the Indian beta-glucan industry was the fastest growing market in the Asia-Pacific region.

    Key Players and Competitive Insights

    Leading market players are investing heavily in research and development in order to expand their product lines, which will help the Beta-Glucan market, grow even more. Market participants are also undertaking a variety of strategic activities to expand their global footprint, with important market developments including new product launches, contractual agreements, mergers and acquisitions, higher investments, and collaboration with other organizations. To expand and survive in a more competitive and rising market climate, Beta-Glucan Industry must offer cost-effective items.

    Manufacturing locally to minimize operational costs is one of the key business tactics used by manufacturers in the global Beta-Glucan Industry to benefit clients and increase the market sector. In recent years, the Beta-Glucan Industry has offered some of the most significant advantages to medicine. Major players in the Beta-Glucan market, including Kerry Group plc., Givaudan SA, Koninklijke DSM N.V., Euglena Co. Ltd, Biotec Pharmacon ASA, Tate & Lyle plc., Lesaffre Group, Kemin Industries, Inc., ABF Ingredients, Super Beta Glucan, and Garuda International, Inc., are attempting to increase market demand by investing in research and development operations.

    Kemin Industries Inc. (Kemin) produces and distributes substances linked to human nutrition and animal health. Its product line includes, among other things, enzymes, probiotics, carotenoids, natural extracts, mould inhibitors, forage preservatives, toxin binders, liquid antibacterial formulations, and antioxidant formulations. These goods are used in a variety of sectors, such as biofuels, personal care, commercial greenhouses, pet food technology, rendering, dietary ingredients, food technologies, and animal nutrition and health. Kemin Industry will be expanding its production facility in December 2022.

    The company's dedication to innovation and sustainability in animal nutrition and health is shown in Kemin's decision to expand its Cavriago production facility.

    The mission of Royal DSM NV (DSM), a science-based company, is to identify environmental, social, and economic challenges and opportunities, seize those opportunities to have a long-lasting positive impact on people and the environment, and then build growth through sustainable, profitable expansion. The business makes speciality plastics, fiber and resin solutions, nutritional lipids, carotenoids, vitamins, and other components. From agriculture byproducts and biochemicals, the company creates materials for renewable energy and medicinal devices.

    The launch of an integrated food and beverage operating structure, which brings together three aspects of DSM's nutrition business—Food Specialties, Hydrocolloids, and a portion of its Nutritional Products Group—was announced by the company in January 2022.

    Key Companies in the Beta Glucan Market market include

    Industry Developments

      • In November 2022, Ceapro Inc. took a step further toward the development of PGX technology for pharmaceuticals and nutraceuticals. So far, Alginate and yeast beta-glucan have been developed as the first bio-actives under this technology. This will help in the further expansion of the company’s innovative product portfolio.
      • In July 2023, BENEO unveiled the company’s very first barley beta-glucan product, the Orafti β-Fit, designed specifically for promoting heart health and the control of blood sugar levels. It is anticipated that this new product will enable BENEO to expand its coverage throughout the world in terms of fiber as well as cardio-metabolic health.
      • In July 2023, Indian pharmaceutical company Dr. Reddy’s Laboratories entered into the infant nutrition space by launching CeleHealth Kidz Immuno Plus Gummies in India. The product seeks to provide a solution for the rising concern regarding diet and immunity for kids in India.
      • It’s interesting to note that Biohymn Biotechnology, which Lesaffre came into possession of in June 2020, is a yeast manufacturing company based in China; this now makes Lesaffre the controlling partner of the company.
      • In June 2020, a collaboration was formed between Tate & Lyle PLC and Solevo, which facilitated Lyle in being able to expand its business across the industrial and agricultural domains in Africa.
    .webp

    Future Outlook

    Beta Glucan Market Future Outlook

    <p>The Beta-Glucan Market is projected to grow at a 5.03% CAGR from 2024 to 2035, driven by increasing health awareness, demand for functional foods, and advancements in biotechnology.</p>

    New opportunities lie in:

    • <p>Development of personalized nutrition products incorporating beta-glucan</p>
    • <p>Expansion into emerging markets with tailored marketing strategies</p>
    • <p>Collaboration with food manufacturers for innovative beta-glucan formulations</p>

    <p>By 2035, the Beta-Glucan Market is expected to achieve robust growth and increased market penetration.</p>

    Market Segmentation

    Beta Glucan Market Type Outlook

    • (1,3) Beta Glucan
    • (1,4) Beta Glucan
    • (1,6) Beta Glucan

    Beta Glucan Market Source Outlook

    • Yeast
    • Mushroom
    • Cereals
    • Microalgae

    Beta Glucan Market Application Outlook

    • Food & Beverages
    • Animal Feed
    • Personal Care
    • Pharmaceuticals
    • Others

    Report Scope

    MARKET SIZE 20241.485(USD Billion)
    MARKET SIZE 20251.56(USD Billion)
    MARKET SIZE 20352.548(USD Billion)
    COMPOUND ANNUAL GROWTH RATE (CAGR)5.03% (2024 - 2035)
    REPORT COVERAGERevenue Forecast, Competitive Landscape, Growth Factors, and Trends
    BASE YEAR2024
    Market Forecast Period2025 - 2035
    Historical Data2019 - 2024
    Market Forecast UnitsUSD Billion
    Key Companies ProfiledMarket analysis in progress
    Segments CoveredMarket segmentation analysis in progress
    Key Market OpportunitiesRising consumer demand for natural health products enhances growth potential in the Beta-Glucan Market.
    Key Market DynamicsRising consumer demand for natural health products drives innovation and competition in the Beta-Glucan market.
    Countries CoveredNorth America, Europe, APAC, South America, MEA

    FAQs

    How much is the Beta-Glucan market?

    The Beta-Glucan Market size was valued at USD 1.4 Billion in 2023.

    What is the growth rate of the Beta-Glucan market?

    The global market is projected to grow at a CAGR of 5.03% during the forecast period, 2024-2032.

    Which region held the largest market share in the Beta-Glucan market?

    North America had the largest share in the global market

    Who are the key players in the Beta-Glucan market?

    The key players in the market are Kerry Group plc., Givaudan SA, Koninklijke DSM N.V., Euglena Co. Ltd, Biotec Pharmacon ASA, Tate &amp; Lyle plc., Lesaffre Group, Kemin Industries, Inc., ABF Ingredients, Super Beta Glucan, and Garuda International, Inc.

    Which Source led the Beta-Glucan market?

    The Yeast Source dominated the market in 2023.

    Which Application had the largest market share in the Beta-Glucan market?

    The Food &amp; Beverages Application had the largest share in the global market.

    1. EXECUTIVE SUMMARY
      1. 2.
    2. MARKET INTRODUCTION
      1. 2.1.
      2. Definition
      3. 2.2.
      4. Scope of the Study
      5. 2.2.1.
      6. Research Objective
      7. 2.2.2.
      8. Assumptions
      9. 2.2.3.
      10. Limitations
      11. 3.
    3. RESEARCH METHODOLOGY
      1. 3.1.
      2. Overview
      3. 3.2.
      4. Data Mining
      5. 3.3.
      6. Secondary Research
      7. 3.4.
      8. Primary Research
      9. 3.4.1.
      10. Primary Interviews and Information Gathering Process
    4. Breakdown of Primary Respondents
      1. Forecasting Model
      2. Market Size Estimation
        1. Bottom-Up Approach
        2. Top-Down Approach
      3. Data Triangulation
      4. Validation
    5. MARKET DYNAMICS
      1. Overview
      2. Drivers
      3. Restraints
      4. Opportunities
    6. MARKET FACTOR ANALYSIS
      1. Value Chain Analysis
      2. Porter’s Five
        1. Bargaining Power of Buyers
        2. Threat of New Entrants
        3. Threat of Substitutes
        4. Intensity of Rivalry
      3. Forces Analysis
      4. 5.2.1.
      5. Bargaining Power of Suppliers
      6. COVID-19 Impact Analysis
        1. Market Impact Analysis
        2. Regional Impact
        3. Opportunity and Threat Analysis
    7. GLOBAL BETA-GLUCAN
    8. MARKET, BY SOURCE
      1. 6.1.
      2. Overview
      3. 6.2.
      4. Yeast
      5. 6.3.
      6. Mushroom
      7. 6.4.
      8. Cereals
      9. 6.5.
      10. Microalgae
      11. 7.
    9. GLOBAL BETA-GLUCAN MARKET, BY APPLICATION
      1. Overview
      2. Food & Beverages
      3. Animal Feed
      4. Personal Care
      5. Pharmaceuticals
      6. Others
    10. GLOBAL BETA-GLUCAN MARKET, BY TYPE
      1. Overview
      2. (1,3) Beta Glucan
      3. (1,4) Beta Glucan
      4. (1,6) Beta Glucan
    11. GLOBAL BETA-GLUCAN
    12. MARKET, BY REGION
      1. 9.1.
      2. Overview
      3. 9.2.
      4. North America
      5. 9.2.1.
      6. U.S.
      7. 9.2.2.
      8. Canada
      9. 9.3.
      10. Europe
      11. 9.3.1.
      12. Germany
      13. 9.3.2.
      14. France
      15. 9.3.3.
      16. U.K
      17. 9.3.4.
      18. Italy
      19. 9.3.5.
      20. Spain
      21. 9.3.6.
      22. Rest of Europe
      23. 9.4.
      24. Asia-Pacific
      25. 9.4.1.
      26. China
      27. 9.4.2.
      28. India
      29. 9.4.3.
      30. Japan
      31. 9.4.4.
      32. South Korea
      33. 9.4.5.
      34. Australia
      35. 9.4.6.
      36. Rest of Asia-Pacific
      37. 9.5.
      38. Rest of the World
      39. 9.5.1.
      40. Middle East
      41. 9.5.2.
      42. Africa
      43. 9.5.3.
      44. Latin America
      45. 10.
    13. COMPETITIVE LANDSCAPE
      1. 10.1.
      2. Overview
      3. 10.2.
      4. Competitive Analysis
      5. 10.3.
      6. Market Share Analysis
      7. 10.4.
      8. Major Growth Strategy in the Global Beta-Glucan Market,
      9. Competitive Benchmarking
      10. Leading Players in Terms
      11. of Number of Developments in the Global Beta-Glucan Market,
      12. Key developments and Growth Strategies
        1. New Product Launch/Application
        2. Joint Ventures
      13. Deployment
      14. 10.7.2.
      15. Merger & Acquisitions
      16. Major Players Financial Matrix
        1. Sales & Operating Income, 2022
        2. Major Players
      17. R&D Expenditure. 2022
    14. COMPANY PROFILES
      1. Kerry Group plc.
        1. Company Overview
        2. Financial Overview
        3. Products Offered
        4. Key Developments
        5. SWOT Analysis
        6. Key Strategies
      2. Givaudan SA
        1. Company Overview
        2. Financial Overview
        3. Products Offered
        4. Key Developments
        5. SWOT Analysis
        6. Key Strategies
      3. Koninklijke DSM N.V.
        1. Company Overview
        2. Financial Overview
        3. Products Offered
        4. Key Developments
        5. SWOT Analysis
        6. Key Strategies
      4. Euglena Co. Ltd
        1. Company Overview
        2. Financial Overview
        3. Products Offered
        4. Key Developments
        5. SWOT Analysis
        6. Key Strategies
      5. Biotec Pharmacon ASA
        1. Company Overview
        2. Financial Overview
        3. Products Offered
        4. Key Developments
        5. SWOT Analysis
        6. Key Strategies
      6. TATE & LYLE PLC.
        1. Company Overview
        2. Financial Overview
        3. Products Offered
        4. Key Developments
        5. SWOT Analysis
        6. Key Strategies
      7. Lesaffre Group
        1. Company Overview
        2. Financial Overview
        3. Products Offered
        4. Key Developments
        5. SWOT Analysis
        6. Key Strategies
      8. Kemin Industries, Inc.
        1. Company Overview
        2. Financial Overview
        3. Products Offered
        4. Key Developments
        5. SWOT Analysis
        6. Key Strategies
      9. ABF Ingredients
        1. Company Overview
        2. Financial Overview
        3. Products Offered
        4. Key Developments
        5. SWOT Analysis
        6. Key Strategies
      10. Super Beta Glucan
        1. Company Overview
        2. Financial Overview
        3. Products Offered
        4. Key Developments
        5. SWOT Analysis
        6. Key Strategies
      11. Garuda International, Inc.
        1. Company Overview
        2. Financial Overview
        3. Products Offered
        4. Key Developments
        5. SWOT Analysis
        6. Key Strategies
    15. APPENDIX
      1. References
      2. Related Reports
    16. LIST OF TABLES
    17. GLOBAL BETA-GLUCAN MARKET,
      1. SYNOPSIS, 2020-2032
      2. TABLE
    18. GLOBAL BETA-GLUCAN MARKET, ESTIMATES & FORECAST, 2020-2032 (USD BILLION)
    19. GLOBAL BETA-GLUCAN
    20. MARKET, BY SOURCE, 2020-2032 (USD BILLION)
    21. GLOBAL BETA-GLUCAN MARKET, BY APPLICATION,
    22. GLOBAL BETA-GLUCAN MARKET, BY TYPE, 2020-2032 (USD BILLION)
    23. NORTH AMERICA
    24. BETA-GLUCAN MARKET, BY SOURCE, 2020-2032 (USD BILLION)
    25. NORTH AMERICA BETA-GLUCAN MARKET, BY APPLICATION,
    26. NORTH AMERICA BETA-GLUCAN MARKET, BY TYPE, 2020-2032 (USD BILLION)
    27. NORTH AMERICA
    28. BETA-GLUCAN MARKET, BY COUNTRY, 2020-2032 (USD BILLION)
    29. U.S. BETA-GLUCAN MARKET, BY SOURCE, 2020-2032
      1. (USD BILLION)
      2. TABLE
    30. U.S. BETA-GLUCAN MARKET, BY APPLICATION, 2020-2032 (USD BILLION)
    31. U.S. BETA-GLUCAN MARKET,
      1. BY TYPE, 2020-2032 (USD BILLION)
    32. CANADA BETA-GLUCAN MARKET, BY SOURCE, 2020-2032 (USD BILLION)
    33. CANADA BETA-GLUCAN
    34. MARKET, BY APPLICATION, 2020-2032 (USD BILLION)
    35. CANADA BETA-GLUCAN MARKET, BY TYPE, 2020-2032
      1. (USD BILLION)
      2. TABLE
    36. EUROPE BETA-GLUCAN MARKET, BY SOURCE, 2020-2032 (USD BILLION)
    37. EUROPE BETA-GLUCAN MARKET,
      1. BY APPLICATION, 2020-2032 (USD BILLION)
    38. EUROPE BETA-GLUCAN MARKET, BY TYPE, 2020-2032 (USD
      1. BILLION)
      2. TABLE
    39. EUROPE BETA-GLUCAN MARKET, BY COUNTRY, 2020-2032 (USD BILLION)
    40. GERMANY BETA-GLUCAN
    41. MARKET, BY SOURCE, 2020-2032 (USD BILLION)
    42. GERMANY BETA-GLUCAN MARKET, BY APPLICATION,
    43. GERMANY BETA-GLUCAN MARKET, BY TYPE, 2020-2032 (USD BILLION)
    44. FRANCE BETA-GLUCAN
    45. MARKET, BY SOURCE, 2020-2032 (USD BILLION)
    46. FRANCE BETA-GLUCAN MARKET, BY APPLICATION,
    47. FRANCE BETA-GLUCAN MARKET, BY TYPE, 2020-2032 (USD BILLION)
    48. ITALY BETA-GLUCAN
    49. MARKET, BY SOURCE, 2020-2032 (USD BILLION)
    50. ITALY BETA-GLUCAN MARKET, BY APPLICATION,
    51. ITALY BETA-GLUCAN MARKET, BY TYPE, 2020-2032 (USD BILLION)
    52. SPAIN BETA-GLUCAN
    53. MARKET, BY SOURCE, 2020-2032 (USD BILLION)
    54. SPAIN BETA-GLUCAN MARKET, BY APPLICATION,
    55. SPAIN BETA-GLUCAN MARKET, BY TYPE, 2020-2032 (USD BILLION)
    56. U.K BETA-GLUCAN
    57. MARKET, BY SOURCE, 2020-2032 (USD BILLION)
    58. U.K BETA-GLUCAN MARKET, BY APPLICATION,
    59. U.K BETA-GLUCAN MARKET, BY TYPE, 2020-2032 (USD BILLION)
    60. REST OF EUROPE
    61. BETA-GLUCAN MARKET, BY SOURCE, 2020-2032 (USD BILLION)
    62. REST OF EUROPE BETA-GLUCAN MARKET, BY APPLICATION,
    63. REST OF EUROPE BETA-GLUCAN MARKET, BY TYPE, 2020-2032 (USD
      1. BILLION)
      2. TABLE
    64. ASIA PACIFIC BETA-GLUCAN MARKET, BY SOURCE, 2020-2032 (USD BILLION)
    65. ASIA PACIFIC
    66. BETA-GLUCAN MARKET, BY APPLICATION, 2020-2032 (USD BILLION)
    67. ASIA PACIFIC BETA-GLUCAN MARKET, BY TYPE,
    68. ASIA PACIFIC BETA-GLUCAN MARKET, BY COUNTRY, 2020-2032 (USD
      1. BILLION)
      2. TABLE
    69. JAPAN BETA-GLUCAN MARKET, BY SOURCE, 2020-2032 (USD BILLION)
    70. JAPAN BETA-GLUCAN MARKET,
      1. BY APPLICATION, 2020-2032 (USD BILLION)
    71. JAPAN BETA-GLUCAN MARKET, BY TYPE, 2020-2032 (USD
      1. BILLION)
      2. TABLE
    72. CHINA BETA-GLUCAN MARKET, BY SOURCE, 2020-2032 (USD BILLION)
    73. CHINA BETA-GLUCAN MARKET,
      1. BY APPLICATION, 2020-2032 (USD BILLION)
    74. CHINA BETA-GLUCAN MARKET, BY TYPE, 2020-2032 (USD
      1. BILLION)
      2. TABLE
    75. INDIA BETA-GLUCAN MARKET, BY SOURCE, 2020-2032 (USD BILLION)
    76. INDIA BETA-GLUCAN MARKET,
      1. BY APPLICATION, 2020-2032 (USD BILLION)
    77. INDIA BETA-GLUCAN MARKET, BY TYPE, 2020-2032 (USD
      1. BILLION)
      2. TABLE
    78. AUSTRALIA BETA-GLUCAN MARKET, BY SOURCE, 2020-2032 (USD BILLION)
    79. AUSTRALIA BETA-GLUCAN
    80. MARKET, BY APPLICATION, 2020-2032 (USD BILLION)
    81. AUSTRALIA BETA-GLUCAN MARKET, BY TYPE, 2020-2032
      1. (USD BILLION)
      2. TABLE
    82. SOUTH KOREA BETA-GLUCAN MARKET, BY SOURCE, 2020-2032 (USD BILLION)
    83. SOUTH KOREA
    84. BETA-GLUCAN MARKET, BY APPLICATION, 2020-2032 (USD BILLION)
    85. SOUTH KOREA BETA-GLUCAN MARKET, BY TYPE,
    86. REST OF ASIA-PACIFIC BETA-GLUCAN MARKET, BY SOURCE, 2020-2032
      1. (USD BILLION)
      2. TABLE
    87. REST OF ASIA-PACIFIC BETA-GLUCAN MARKET, BY APPLICATION, 2020-2032 (USD BILLION)
    88. REST OF ASIA-PACIFIC
    89. BETA-GLUCAN MARKET, BY TYPE, 2020-2032 (USD BILLION)
    90. REST OF WORLD BETA-GLUCAN MARKET, BY SOURCE,
    91. REST OF WORLD BETA-GLUCAN MARKET, BY APPLICATION, 2020-2032
      1. (USD BILLION)
      2. TABLE
    92. REST OF WORLD BETA-GLUCAN MARKET, BY TYPE, 2020-2032 (USD BILLION)
    93. REST OF WORLD
    94. BETA-GLUCAN MARKET, BY COUNTRY, 2020-2032 (USD BILLION)
    95. MIDDLE EAST BETA-GLUCAN MARKET, BY SOURCE,
    96. MIDDLE EAST BETA-GLUCAN MARKET, BY APPLICATION, 2020-2032
      1. (USD BILLION)
      2. TABLE
    97. MIDDLE EAST BETA-GLUCAN MARKET, BY TYPE, 2020-2032 (USD BILLION)
    98. AFRICA BETA-GLUCAN MARKET,
      1. BY SOURCE, 2020-2032 (USD BILLION)
    99. AFRICA BETA-GLUCAN MARKET, BY APPLICATION, 2020-2032
      1. (USD BILLION)
      2. TABLE
    100. AFRICA BETA-GLUCAN MARKET, BY TYPE, 2020-2032 (USD BILLION)
    101. LATIN AMERICA BETA-GLUCAN
    102. MARKET, BY SOURCE, 2020-2032 (USD BILLION)
    103. LATIN AMERICA BETA-GLUCAN MARKET, BY APPLICATION,
    104. LATIN AMERICA BETA-GLUCAN MARKET, BY TYPE, 2020-2032 (USD
      1. BILLION) 
      2. LIST
    105. OF FIGURES
      1. FIGURE
    106. RESEARCH PROCESS
      1. FIGURE
    107. MARKET STRUCTURE FOR THE GLOBAL BETA-GLUCAN MARKET
    108. MARKET DYNAMICS FOR THE GLOBAL BETA-GLUCAN
      1. MARKET
      2. FIGURE
    109. GLOBAL BETA-GLUCAN MARKET, SHARE (%), BY SOURCE, 2022
    110. GLOBAL BETA-GLUCAN MARKET, SHARE (%), BY
      1. APPLICATION, 2022
      2. FIGURE
    111. GLOBAL BETA-GLUCAN MARKET, SHARE (%), BY TYPE, 2022
    112. GLOBAL BETA-GLUCAN MARKET, SHARE (%), BY
      1. REGION, 2022
      2. FIGURE
    113. NORTH AMERICA: BETA-GLUCAN MARKET, SHARE (%), BY REGION, 2022
    114. EUROPE: BETA-GLUCAN
    115. MARKET, SHARE (%), BY REGION, 2022
    116. ASIA-PACIFIC: BETA-GLUCAN MARKET, SHARE (%), BY
      1. REGION, 2022
      2. FIGURE
    117. REST OF THE WORLD: BETA-GLUCAN MARKET, SHARE (%), BY REGION, 2022
    118. GLOBAL BETA-GLUCAN
      1. MARKET: COMPANY SHARE ANALYSIS, 2022 (%)
    119. KERRY GROUP PLC.: FINANCIAL OVERVIEW SNAPSHOT
    120. KERRY GROUP
      1. PLC.: SWOT ANALYSIS
      2. FIGURE
    121. GIVAUDAN SA: FINANCIAL OVERVIEW SNAPSHOT
    122. GIVAUDAN SA: SWOT ANALYSIS
    123. KONINKLIJKE DSM N.V.:
      1. FINANCIAL OVERVIEW SNAPSHOT
    124. KONINKLIJKE DSM N.V.: SWOT ANALYSIS
    125. EUGLENA CO. LTD: FINANCIAL OVERVIEW SNAPSHOT
    126. EUGLENA CO.
      1. LTD: SWOT ANALYSIS
      2. FIGURE
    127. BIOTEC PHARMACON ASA.: FINANCIAL OVERVIEW SNAPSHOT
    128. BIOTEC PHARMACON ASA.: SWOT ANALYSIS
    129. TATE &
      1. LYLE PLC.: FINANCIAL OVERVIEW SNAPSHOT
    130. TATE & LYLE PLC.: SWOT ANALYSIS
    131. LESAFFRE GROUP:
      1. FINANCIAL OVERVIEW SNAPSHOT
    132. LESAFFRE GROUP: SWOT ANALYSIS
    133. KEMIN INDUSTRIES, INC.: FINANCIAL OVERVIEW
      1. SNAPSHOT
      2. FIGURE
    134. KEMIN INDUSTRIES, INC.: SWOT ANALYSIS
    135. ABF INGREDIENTS: FINANCIAL OVERVIEW SNAPSHOT
    136. ABF INGREDIENTS:
    137. SWOT ANALYSIS
      1. FIGURE
    138. SUPER BETA GLUCAN: FINANCIAL OVERVIEW SNAPSHOT
    139. SUPER BETA GLUCAN: SWOT ANALYSIS
    140. GARUDA INTERNATIONAL,
      1. INC.: FINANCIAL OVERVIEW SNAPSHOT
    141. GARUDA INTERNATIONAL, INC.: SWOT ANALYSIS

    Beta-Glucan Market Segmentation

    Beta-Glucan Source Outlook (USD Billion, 2018-2032)

    • Yeast
    • Mushroom
    • Cereals
    • Microalgae

    Beta-Glucan Application Outlook (USD Billion, 2018-2032)

    • Food & Beverages
    • Animal Feed
    • Personal Care
    • Pharmaceuticals
    • Others

    Beta-Glucan Type Outlook (USD Billion, 2018-2032)

    • (1,3) Beta Glucan
    • (1,4) Beta Glucan
    • (1,6) Beta Glucan

    Beta-Glucan Regional Outlook (USD Billion, 2018-2032)

    • North America Outlook (USD Billion, 2018-2032)

      • Beta-Glucan by Source
        • Yeast
        • Mushroom
        • Cereals
        • Microalgae
      • Beta-Glucan Application Outlook (USD Billion, 2018-2032)

        • Food & Beverages
        • Animal Feed
        • Personal Care
        • Pharmaceuticals
        • Others
      • Beta-Glucan Type Outlook (USD Billion, 2018-2032)

        • (1,3) Beta Glucan
        • (1,4) Beta Glucan
        • (1,6) Beta Glucan
      • US Outlook (USD Billion, 2018-2032)

      • Beta-Glucan by Source
        • Yeast
        • Mushroom
        • Cereals
        • Microalgae
      • Beta-Glucan Application Outlook (USD Billion, 2018-2032)

        • Food & Beverages
        • Animal Feed
        • Personal Care
        • Pharmaceuticals
        • Others
      • Beta-Glucan Type Outlook (USD Billion, 2018-2032)

        • (1,3) Beta Glucan
        • (1,4) Beta Glucan
        • (1,6) Beta Glucan
      • Canada Outlook (USD Billion, 2018-2032)

      • Beta-Glucan by Source
        • Yeast
        • Mushroom
        • Cereals
        • Microalgae
      • Beta-Glucan Application Outlook (USD Billion, 2018-2032)

        • Food & Beverages
        • Animal Feed
        • Personal Care
        • Pharmaceuticals
        • Others
      • Beta-Glucan Type Outlook (USD Billion, 2018-2032)

        • (1,3) Beta Glucan
        • (1,4) Beta Glucan
        • (1,6) Beta Glucan
    • Europe Outlook (USD Billion, 2018-2032)

      • Beta-Glucan by Source
        • Yeast
        • Mushroom
        • Cereals
        • Microalgae
      • Beta-Glucan Application Outlook (USD Billion, 2018-2032)

        • Food & Beverages
        • Animal Feed
        • Personal Care
        • Pharmaceuticals
        • Others
      • Beta-Glucan Type Outlook (USD Billion, 2018-2032)

        • (1,3) Beta Glucan
        • (1,4) Beta Glucan
        • (1,6) Beta Glucan
      • Germany Outlook (USD Billion, 2018-2032)

      • Beta-Glucan by Source
        • Yeast
        • Mushroom
        • Cereals
        • Microalgae
      • Beta-Glucan Application Outlook (USD Billion, 2018-2032)

        • Food & Beverages
        • Animal Feed
        • Personal Care
        • Pharmaceuticals
        • Others
      • Beta-Glucan Type Outlook (USD Billion, 2018-2032)

        • (1,3) Beta Glucan
        • (1,4) Beta Glucan
        • (1,6) Beta Glucan
      • France Outlook (USD Billion, 2018-2032)

      • Beta-Glucan by Source
        • Yeast
        • Mushroom
        • Cereals
        • Microalgae
      • Beta-Glucan Application Outlook (USD Billion, 2018-2032)

        • Food & Beverages
        • Animal Feed
        • Personal Care
        • Pharmaceuticals
        • Others
      • Beta-Glucan Type Outlook (USD Billion, 2018-2032)

        • (1,3) Beta Glucan
        • (1,4) Beta Glucan
        • (1,6) Beta Glucan
      • UK Outlook (USD Billion, 2018-2032)

      • Beta-Glucan by Source
        • Yeast
        • Mushroom
        • Cereals
        • Microalgae
      • Beta-Glucan Application Outlook (USD Billion, 2018-2032)

        • Food & Beverages
        • Animal Feed
        • Personal Care
        • Pharmaceuticals
        • Others
      • Beta-Glucan Type Outlook (USD Billion, 2018-2032)

        • (1,3) Beta Glucan
        • (1,4) Beta Glucan
        • (1,6) Beta Glucan
      • Italy Outlook (USD Billion, 2018-2032)

      • Beta-Glucan by Source
        • Yeast
        • Mushroom
        • Cereals
        • Microalgae
      • Beta-Glucan Application Outlook (USD Billion, 2018-2032)

        • Food & Beverages
        • Animal Feed
        • Personal Care
        • Pharmaceuticals
        • Others
      • Beta-Glucan Type Outlook (USD Billion, 2018-2032)

        • (1,3) Beta Glucan
        • (1,4) Beta Glucan
        • (1,6) Beta Glucan
      • Spain Outlook (USD Billion, 2018-2032)

      • Beta-Glucan by Source
        • Yeast
        • Mushroom
        • Cereals
        • Microalgae
      • Beta-Glucan Application Outlook (USD Billion, 2018-2032)

        • Food & Beverages
        • Animal Feed
        • Personal Care
        • Pharmaceuticals
        • Others
      • Beta-Glucan Type Outlook (USD Billion, 2018-2032)

        • (1,3) Beta Glucan
        • (1,4) Beta Glucan
        • (1,6) Beta Glucan
      • Rest Of Europe Outlook (USD Billion, 2018-2032)

      • Beta-Glucan by Source
        • Yeast
        • Mushroom
        • Cereals
        • Microalgae
      • Beta-Glucan Application Outlook (USD Billion, 2018-2032)

        • Food & Beverages
        • Animal Feed
        • Personal Care
        • Pharmaceuticals
        • Others
      • Beta-Glucan Type Outlook (USD Billion, 2018-2032)

        • (1,3) Beta Glucan
        • (1,4) Beta Glucan
        • (1,6) Beta Glucan
    • Asia-Pacific Outlook (USD Billion, 2018-2032)

      • Beta-Glucan by Source
        • Yeast
        • Mushroom
        • Cereals
        • Microalgae
      • Beta-Glucan Application Outlook (USD Billion, 2018-2032)

        • Food & Beverages
        • Animal Feed
        • Personal Care
        • Pharmaceuticals
        • Others
      • Beta-Glucan Type Outlook (USD Billion, 2018-2032)

        • (1,3) Beta Glucan
        • (1,4) Beta Glucan
        • (1,6) Beta Glucan
      • China Outlook (USD Billion, 2018-2032)

      • Beta-Glucan by Source
        • Yeast
        • Mushroom
        • Cereals
        • Microalgae
      • Beta-Glucan Application Outlook (USD Billion, 2018-2032)

        • Food & Beverages
        • Animal Feed
        • Personal Care
        • Pharmaceuticals
        • Others
      • Beta-Glucan Type Outlook (USD Billion, 2018-2032)

        • (1,3) Beta Glucan
        • (1,4) Beta Glucan
        • (1,6) Beta Glucan
      • Japan Outlook (USD Billion, 2018-2032)

      • Beta-Glucan by Source
        • Yeast
        • Mushroom
        • Cereals
        • Microalgae
      • Beta-Glucan Application Outlook (USD Billion, 2018-2032)

        • Food & Beverages
        • Animal Feed
        • Personal Care
        • Pharmaceuticals
        • Others
      • Beta-Glucan Type Outlook (USD Billion, 2018-2032)

        • (1,3) Beta Glucan
        • (1,4) Beta Glucan
        • (1,6) Beta Glucan
      • India Outlook (USD Billion, 2018-2032)

      • Beta-Glucan by Source
        • Yeast
        • Mushroom
        • Cereals
        • Microalgae
      • Beta-Glucan Application Outlook (USD Billion, 2018-2032)

        • Food & Beverages
        • Animal Feed
        • Personal Care
        • Pharmaceuticals
        • Others
      • Beta-Glucan Type Outlook (USD Billion, 2018-2032)

        • (1,3) Beta Glucan
        • (1,4) Beta Glucan
        • (1,6) Beta Glucan
      • Australia Outlook (USD Billion, 2018-2032)

      • Beta-Glucan by Source
        • Yeast
        • Mushroom
        • Cereals
        • Microalgae
      • Beta-Glucan Application Outlook (USD Billion, 2018-2032)

        • Food & Beverages
        • Animal Feed
        • Personal Care
        • Pharmaceuticals
        • Others
      • Beta-Glucan Type Outlook (USD Billion, 2018-2032)

        • (1,3) Beta Glucan
        • (1,4) Beta Glucan
        • (1,6) Beta Glucan
      • Rest of Asia-Pacific Outlook (USD Billion, 2018-2032)

      • Beta-Glucan by Source
        • Yeast
        • Mushroom
        • Cereals
        • Microalgae
      • Beta-Glucan Application Outlook (USD Billion, 2018-2032)

        • Food & Beverages
        • Animal Feed
        • Personal Care
        • Pharmaceuticals
        • Others
      • Beta-Glucan Type Outlook (USD Billion, 2018-2032)

        • (1,3) Beta Glucan
        • (1,4) Beta Glucan
        • (1,6) Beta Glucan
    • Rest of the World Outlook (USD Billion, 2018-2032)

      • Beta-Glucan by Source
        • Yeast
        • Mushroom
        • Cereals
        • Microalgae
      • Beta-Glucan Application Outlook (USD Billion, 2018-2032)

        • Food & Beverages
        • Animal Feed
        • Personal Care
        • Pharmaceuticals
        • Others
      • Beta-Glucan Type Outlook (USD Billion, 2018-2032)

        • (1,3) Beta Glucan
        • (1,4) Beta Glucan
        • (1,6) Beta Glucan
      • Middle East Outlook (USD Billion, 2018-2032)

      • Beta-Glucan by Source
        • Yeast
        • Mushroom
        • Cereals
        • Microalgae
      • Beta-Glucan Application Outlook (USD Billion, 2018-2032)

        • Food & Beverages
        • Animal Feed
        • Personal Care
        • Pharmaceuticals
        • Others
      • Beta-Glucan Type Outlook (USD Billion, 2018-2032)

        • (1,3) Beta Glucan
        • (1,4) Beta Glucan
        • (1,6) Beta Glucan
      • Africa Outlook (USD Billion, 2018-2032)

      • Beta-Glucan by Source
        • Yeast
        • Mushroom
        • Cereals
        • Microalgae
      • Beta-Glucan Application Outlook (USD Billion, 2018-2032)

        • Food & Beverages
        • Animal Feed
        • Personal Care
        • Pharmaceuticals
        • Others
      • Beta-Glucan Type Outlook (USD Billion, 2018-2032)

        • (1,3) Beta Glucan
        • (1,4) Beta Glucan
        • (1,6) Beta Glucan
      • Latin America Outlook (USD Billion, 2018-2032)

      • Beta-Glucan by Source
        • Yeast
        • Mushroom
        • Cereals
        • Microalgae
      • Beta-Glucan Application Outlook (USD Billion, 2018-2032)

        • Food & Beverages
        • Animal Feed
        • Personal Care
        • Pharmaceuticals
        • Others
      • Beta-Glucan Type Outlook (USD Billion, 2018-2032)

        • (1,3) Beta Glucan
        • (1,4) Beta Glucan
        • (1,6) Beta Glucan
    Infographic

    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Get Free Sample

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne

    Founder
    Case Study
    Chemicals and Materials

    Compare Licence

    ×
    Features License Type
    Single User Multiuser License Enterprise User
    Price $4,950 $5,950 $7,250
    Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
    Free Customization
    Direct Access to Analyst
    Deliverable Format
    Platform Access
    Discount on Next Purchase 10% 15% 15%
    Printable Versions